Fate Therapeutics shares owned by Redmile Group
Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Redmile Group
from 13F filings
Historical chart of Redmile Group investment in Fate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fate Therapeutics held by Redmile Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fate Therapeutics by Redmile Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $46M | 13M | 3.50 |
| 2024-06-30 | $43M | 13M | 3.28 |
| 2024-03-31 | $97M | 13M | 7.34 |
| 2023-12-31 | $49M | 13M | 3.74 |
| 2023-09-30 | $28M | 13M | 2.12 |
| 2023-06-30 | $63M | 13M | 4.76 |
| 2023-03-31 | $74M | 13M | 5.70 |
| 2022-12-31 | $131M | 13M | 10.09 |
| 2022-09-30 | $290M | 13M | 22.41 |
| 2022-06-30 | $321M | 13M | 24.78 |
| 2022-03-31 | $502M | 13M | 38.77 |
| 2021-12-31 | $758M | 13M | 58.51 |
| 2021-09-30 | $768M | 13M | 59.27 |
| 2021-06-30 | $1.1B | 13M | 86.79 |
| 2021-03-31 | $1.1B | 13M | 82.45 |
| 2020-12-31 | $1.1B | 13M | 90.93 |
| 2020-09-30 | $505M | 13M | 39.97 |
| 2020-06-30 | $433M | 13M | 34.31 |
| 2020-03-31 | $249M | 11M | 22.21 |
| 2019-12-31 | $220M | 11M | 19.57 |
| 2019-09-30 | $174M | 11M | 15.53 |
| 2019-06-30 | $210M | 10M | 20.30 |
| 2019-03-31 | $182M | 10M | 17.57 |
| 2018-12-31 | $136M | 11M | 12.83 |
| 2018-09-30 | $169M | 10M | 16.29 |
| 2018-06-30 | $76M | 6.7M | 11.34 |
| 2018-03-31 | $65M | 6.7M | 9.76 |
| 2017-12-31 | $33M | 5.5M | 6.11 |
| 2017-09-30 | $5.6M | 1.4M | 3.96 |
| 2017-06-30 | $4.6M | 1.4M | 3.24 |
| 2017-03-31 | $6.5M | 1.4M | 4.55 |
| 2016-12-31 | $3.6M | 1.4M | 2.51 |
| 2016-09-30 | $4.4M | 1.4M | 3.12 |
| 2016-06-30 | $2.6M | 1.5M | 1.70 |
| 2016-03-31 | $2.7M | 1.5M | 1.80 |
| 2015-12-31 | $8.0M | 2.4M | 3.37 |
| 2015-09-30 | $11M | 2.1M | 5.33 |
| 2015-06-30 | $13M | 2.0M | 6.47 |